Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke. "EBCAS"

Recruiting

Phase 4 Results N/A

Summary of Purpose

This is a randomized, triple-blind, placebo-controlled, multicenter clinical trial. investigators plan to enroll 774 eligible patients, which will be randomized into either the butylphthalide (NBP) or placebo group in a 2:1 ratio.The main purpose of this study is to determine whether butylphthalide can improve dynamic Cerebral Autoregulation (dCA) in large-artery atherosclerosis acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 April 2018.

28 Feb 2018 18 Jan 2018 1 Feb 2020 1 Jul 2020 1 Apr 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts